59.85 USD
↗ 2.16 (3.74%)AT CLOSE (11:59 AM EDT)
Tarsus Pharmaceuticals, Inc. Common Stock
TARSNASDAQ • USD
59.93
↗ 0.07 (0.13%)
POST MARKET (AS OF 05:14 PM EDT)
Post Market
AS OF 05:14 PM EDT
59.93
↗ 0.07 (0.13%)
Market: CLOSED
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) trades at $59.80 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place TARS at a fair price relative to peers.
Technical & fundamental data as of Jul 17, 2026.
Open?$57.38
High?$59.95
Low?$57.38
Prev. Close?$57.69
Volume?971.2K
Avg. Volume?1.1M
VWAP?$59.07
Rel. Volume?0.87x
Bid / Ask
Bid?$50.98 × 100
Ask?$70.68 × 100
Spread?$19.70
Midpoint?$60.83
Valuation & Ratios
Market Cap?2.5B
Shares Out?43.0M
Float?36.7M
Float %?86.2%
P/E Ratio?N/A
P/B Ratio?7.21
EPS?-$1.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Employees
370
Market Cap
2.5B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
15440 LAGUNA CANYON ROAD
IRVINE, CA 92618
Phone: (949) 409-9820
IRVINE, CA 92618
Phone: (949) 409-9820
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?97
Short Sent.?15
Piotroski F-Score?4/9Mixed
Altman Z-Score?6.91Safe
Confidence?55%Low
Short InterestHigh
Short % of Float?16.06%High
Short Interest?5.9M
Days to Cover?6.2
Free Float36.7M
Avg Daily Volume943.2K
Settlement Date2026-06-30
Financial Health
Current Ratio?3.74Strong
Quick Ratio?3.71Strong
Cash Ratio?0.71Adequate
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?7.21FAIR▾
Peers100
S&P26
P/S?4.70FAIR▾
Peers100
S&P31
P/FCF?N/A▾
EV/EBITDA?-44.9CHEAP▾
S&P97
EV/Sales?4.65FAIR▾
Peers100
S&P39
Returns & Efficiency
ROE?-14.0%WEAK▾
S&P9
ROA?-8.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-31539000
Enterprise Value?$2.5B
Fundamentals ratios updated end of day